Company Performance Metrics
Crownlands develops precision medicines for neurodegenerative and central nervous system diseases using human neuronal data and artificial intelligence. Crownlands operates a discovery platform that generates longitudinal datasets from human neurons to identify disease-driving biology rather than simple correlations. The company applies these
insights to define patient subgroups, design precision clinical trials, and nominate new disease-modifying drug targets. Crownlands also provides a biomarker platform that uses clinically accessible neuron data to guide trial recruitment, stratify patients, and track pharmacodynamic effects. Its Gateway offering sequences human olfactory neurons at scale to create a large neuron biobank that supports neuroscience research and drug discovery.
